Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...
Boehringer Ingelheim, IP Group, UK Respiratory Gene Therapy Consortium, and OXB launched the first-in-human clinical trial, known as LENTICLAIR 1.
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
In today’s fast-paced world, respiratory health is often overlooked, yet it plays a critical role in overall well-being. For ...
Millions of Brits live with asthma and rely on a variety of treatments to manage their condition, but a new study has raised ...
In today’s fast-paced world, respiratory health has become a significant concern for many. Conditions like asthma, Chronic ...
In today’s fast-paced world, respiratory health has become a pressing concern for many. With increasing pollution, sedentary ...
In today’s fast-paced world, respiratory health has become a significant concern for many individuals. Conditions such as ...
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...